GO:1902410 mitotic cytokinetic process: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1902410 (mitotic cytokinetic process) describes the final step of mitosis in which the cytoplasm is physically divided between two daughter cells.
The process is driven by an actomyosin contractile ring, membrane remodeling, and the ESCRT-III machinery that executes abscission.
Key regulators include PLK1, the ESCRT-III subunit CHMP4C, Rab14/MACF2, and integrin adhesion complexes.
Failure of abscission can cause genome instability, a hallmark of cancer and a target for therapeutic intervention.
CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect gene function in mitotic cytokinesis.
EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate cytokinetic research.

Description

Mitotic cytokinetic process (GO:1902410) is the biological process that physically separates the cytoplasm of a dividing cell into two daughter cells after chromosome segregation. It is a highly coordinated event that ensures genomic integrity and is essential for development, tissue homeostasis, and tumor suppression. Defects in this process lead to binucleation, aneuploidy, and cancer, making it a critical area of cell biology research. The process involves the assembly and constriction of an actomyosin ring, membrane trafficking, and the final scission step known as abscission, which is executed by the ESCRT machinery. Recent studies have revealed that proteins such as AGO2 and Rab14 are compartmentalized to the cytokinetic bridge and midbody, highlighting the complexity of this process. Understanding the molecular players and their regulation is vital for developing targeted therapies against diseases linked to cytokinesis failure. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:1902410, its genes, functions, and research methodologies.

mitotic cytokinetic process At A Glance

GO ID GO:1902410
GO term mitotic cytokinetic process
Ontology biological_process
Synonym None
Major function Physical separation of daughter cells during mitosis
Key structures Actomyosin contractile ring, midbody, cytokinetic bridge, abscission site
Key regulators PLK1, ESCRT-III (CHMP4C), Rab14/MACF2, integrins
Related diseases Cancer, genome instability, developmental disorders

What Is GO:1902410?

According to the Gene Ontology, GO:1902410 (mitotic cytokinetic process) is defined as any cytokinetic process that is involved in the mitotic cell cycle. In simpler terms, it encompasses all the cellular events that lead to the physical division of a mitotic cell into two daughter cells, including contractile ring formation, ingression, midbody formation, and abscission.

Why Is mitotic cytokinetic process Important in Cell Biology?

Mitotic cytokinetic process is fundamental to life because it ensures that each daughter cell receives a complete copy of the genome and appropriate cytoplasmic contents. Errors in this process result in tetraploidy or aneuploidy, which are hallmarks of cancer and are associated with tumor progression and chemoresistance. Moreover, cytokinesis is a potential therapeutic target, as rapidly dividing cancer cells are particularly sensitive to perturbations in cell division. Understanding the molecular mechanisms of cytokinesis also sheds light on developmental processes, stem cell renewal, and tissue regeneration.
Ensures genomic stability by preventing binucleation and aneuploidy.
Essential for normal development and tissue homeostasis.
Dysregulation is linked to cancer, including breast, liver, and colorectal cancers.
Provides targets for anti-cancer drugs that inhibit cytokinesis.
Involves ESCRT-III machinery, which is implicated in neurodegeneration and viral budding.
Requires precise spatiotemporal regulation by kinases such as PLK1.
Crosstalk with membrane trafficking pathways (Rab14/MACF2) influences abscission timing.
Integrin-mediated adhesion to the extracellular matrix modulates abscission and genome integrity.
Tension forces from the environment can trigger abscission in fibroblasts.
Non-canonical roles of RNAi components (AGO2) in cytokinesis have been discovered.

What Happens During mitotic cytokinetic process?

Contractile Ring Assembly and Ingression
In simple terms: The cell builds a belt of actin and myosin that tightens to pinch the cell in two.
During anaphase, the mitotic spindle signals the assembly of an actomyosin contractile ring at the equatorial cortex. This ring is composed of actin filaments, myosin II, and associated proteins such as anillin and septins. The small GTPase RhoA activates formin and ROCK to promote actin polymerization and myosin activation, leading to ring constriction and cleavage furrow ingression. PLK1 regulates multiple steps of cytokinesis, including contractile ring formation and abscission.
Midbody Formation and Membrane Remodeling
In simple terms: The narrow bridge between daughter cells becomes a signaling hub called the midbody.
As the cleavage furrow ingresses, the central spindle microtubules bundle to form the midbody, a dense structure that serves as a platform for abscission regulators. Membrane trafficking pathways, including Rab14/MACF2-mediated endosomal targeting, deliver lipids and proteins to the intercellular bridge to facilitate abscission. The midbody also recruits ESCRT components, such as CHMP4C, which are essential for the final scission step.
Abscission and ESCRT-III Function
In simple terms: The ESCRT machinery cuts the final thread connecting the two cells.
Abscission is the final step of cytokinesis, where the thin intercellular bridge is severed. The ESCRT-III complex, including CHMP4C, polymerizes into filaments that constrict and scission the membrane. A cancer-associated polymorphism in CHMP4C disrupts the abscission checkpoint, leading to genome instability. PLK1 phosphorylates ESCRT-III components to regulate abscission timing.
Regulation by Tension and Adhesion
In simple terms: Physical forces and cell adhesion can influence when and how abscission occurs.
Integrin-mediated adhesion to the extracellular matrix contributes to cytokinetic abscission and genomic integrity. Tension-induced abscission has been observed in human fibroblasts, where mechanical forces trigger the final scission step. These findings highlight the interplay between mechanical cues and biochemical pathways in cytokinesis.
Non-canonical Roles of RNAi Components
In simple terms: Proteins usually involved in RNA interference also help control cytokinesis.
AGO2, a core component of the RNA-induced silencing complex, is compartmentalized to the centrosome, mitotic spindle, and cytokinetic bridge in human liver cells, suggesting a non-canonical, RNAi-dependent control of local homeostasis during mitosis. This expands the known functions of RNAi machinery beyond gene silencing.

Key Genes Involved in GO:1902410 mitotic cytokinetic process

The following genes and proteins are key players in the mitotic cytokinetic process, as supported by verified literature.
GeneMajor RoleResearch Relevance
PLK1Kinase regulating contractile ring formation and abscissionTarget for anti-mitotic drugs; regulates ESCRT-III
CHMP4CESCRT-III subunit; abscission checkpointPolymorphism linked to cancer and genome instability
Rab14Endosomal targeting during cytokinesisRegulates membrane trafficking for abscission
MACF2Partner of Rab14 in endosomal targetingComplex with Rab14 controls abscission
AGO2RNAi component; localizes to cytokinetic bridgeNon-canonical role in mitosis
IntegrinsCell adhesion receptorsModulate abscission and genomic integrity
ESCRT-IIIMembrane scission machineryCentral to abscission; linked to cancer
RhoAGTPase activating contractile ringMaster regulator of cytokinesis
AnillinActin-binding protein in contractile ringScaffold for ring assembly
Myosin IIMotor protein for ring contractionForce generation for ingression
ActinCytoskeletal filamentContractile ring component
SeptinsFilament-forming proteinsStabilize the cleavage furrow
Cep55Midbody proteinRecruits ESCRT machinery
ALIXESCRT-associated proteinFacilitates abscission
TSG101ESCRT-I componentRequired for abscission
VPS4AAA-ATPaseRecycles ESCRT-III
SpastinMicrotubule-severing enzymeRequired for midbody microtubule disassembly

How Is mitotic cytokinetic process Regulated?

The mitotic cytokinetic process is tightly regulated by phosphorylation, ubiquitination, and mechanical forces. PLK1 is a key kinase that controls multiple steps, including contractile ring assembly and abscission, through phosphorylation of substrates such as ESCRT-III components. The ESCRT-III abscission checkpoint delays scission in response to chromatin bridges or nuclear defects, preventing genome instability. Rab14/MACF2-mediated endosomal trafficking regulates membrane delivery to the intercellular bridge. Integrin-mediated adhesion and tension also modulate abscission timing and fidelity. Additionally, non-canonical RNAi components like AGO2 may contribute to local homeostasis at the cytokinetic bridge.

mitotic cytokinetic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
CHMP4CCancer, genome instabilityKnock-in of cancer-associated polymorphism in cell lines
PLK1Cancer, mitotic defectsKnockout or overexpression in cancer cell lines
Rab14Cancer, membrane trafficking defectsKnockout in HeLa cells
IntegrinsCancer, developmental disordersKnockout in fibroblasts
AGO2Cancer, RNAi dysfunctionKnockout in liver cancer cells
Cancer and Genome Instability
Defects in mitotic cytokinetic process lead to binucleation, aneuploidy, and chromosomal instability, which are hallmarks of cancer. A cancer-associated polymorphism in CHMP4C disrupts the abscission checkpoint, promoting genome instability. Overexpression of PLK1 is observed in many cancers and is associated with poor prognosis. Targeting cytokinesis regulators is a promising anti-cancer strategy.
Developmental Disorders
Proper cytokinesis is essential for embryonic development and tissue morphogenesis. Mutations in cytokinesis genes can cause developmental disorders, although specific diseases are still being defined. Integrin-mediated adhesion defects during cytokinesis may contribute to developmental abnormalities.
Neurodegeneration
The ESCRT machinery, which is central to abscission, is also involved in neuronal maintenance and its dysfunction is linked to neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia. However, direct links between cytokinetic ESCRT function and neurodegeneration require further investigation.

From mitotic cytokinetic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate abscission?CRISPR knockout in HeLa or U2OS cells followed by live-cell imaging
Does a point mutation in CHMP4C affect abscission checkpoint?Knock-in of mutant CHMP4C in diploid cells
How does PLK1 phosphorylation control cytokinesis?Point mutation of PLK1 phosphorylation sites
What is the role of Rab14 in membrane trafficking during cytokinesis?Knockout and rescue with tagged Rab14
Does AGO2 localize to the cytokinetic bridge?Tagged knock-in of AGO2 with fluorescent protein
How does tension affect abscission?Overexpression of mechanosensitive proteins in fibroblasts

How to Study the mitotic cytokinetic process Process

MethodWhat It MeasuresTypical Application
Live-cell imagingDynamics of contractile ring and abscissionVisualize cytokinesis in real time
CRISPR knockoutGene function in cytokinesisIdentify essential genes
Proximity labeling (BioID)Protein interactions at midbodyMap local interactome
ImmunofluorescenceLocalization of proteins to midbodyValidate candidate genes
RNA-seqTranscriptional changes upon cytokinesis failureIdentify pathways affected
PhosphoproteomicsKinase substrates during mitosisMap PLK1 targets
Tension sensors (FRET)Mechanical forces at cleavage furrowStudy tension-induced abscission
Live-Cell Imaging
Live-cell imaging with fluorescently tagged proteins (e.g., GFP-actin, mCherry-ESCRT-III) allows real-time visualization of contractile ring dynamics, midbody formation, and abscission. This method is essential for assessing the timing and fidelity of cytokinesis in response to genetic perturbations.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify novel regulators of cytokinesis by selecting for cells that survive or exhibit specific phenotypes, such as binucleation. These screens are powerful for discovering new genes involved in abscission and genome stability.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify protein-protein interactions at the midbody and cytokinetic bridge. Proximity labeling (BioID) can map the local proteome of the intercellular bridge, revealing new components.
RNA Interference and CRISPR Interference
RNAi and CRISPRi knockdown of candidate genes followed by immunofluorescence for midbody markers (e.g., Cep55, CHMP4C) can rapidly assess their role in cytokinesis. These methods are complementary to knockout approaches.

How CRISPR Can Be Used to Study GO:1902410 mitotic cytokinetic process

Knockout

CRISPR knockout of genes such as PLK1, CHMP4C, or Rab14 in cell lines (e.g., HeLa, U2OS) can reveal their essential roles in cytokinesis. For example, CHMP4C knockout leads to abscission checkpoint defects and genome instability. Knockout of Rab14 impairs endosomal targeting and abscission.

Point Mutation

Introducing point mutations via CRISPR base editing or HDR can model cancer-associated polymorphisms, such as the CHMP4C variant that disrupts the abscission checkpoint. Point mutations in PLK1 phosphorylation sites can dissect its specific roles in cytokinesis.

Knock-in

Knock-in of fluorescent tags (e.g., GFP, mCherry) into endogenous loci allows real-time tracking of proteins like AGO2 at the cytokinetic bridge. Knock-in of mutant alleles can also model disease-associated variants.

Overexpression

Overexpression of cytokinesis regulators, such as PLK1 or ESCRT-III components, can induce aberrant cytokinesis and is useful for studying gain-of-function effects. Overexpression of mechanosensitive proteins can mimic tension-induced abscission.

How EDITGENE Supports mitotic cytokinetic process Research

Researchers studying mitotic cytokinetic process-related genes often need to determine whether a candidate gene is causally involved in abscission, contractile ring dynamics, or genome stability. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for mitotic cytokinetic process research.

Frequently Asked Questions About mitotic cytokinetic process

GO:1902410 is a Gene Ontology term for any cytokinetic process involved in the mitotic cell cycle, including contractile ring formation, ingression, and abscission.
Key genes include PLK1, CHMP4C, Rab14, MACF2, AGO2, and integrins, among others.
ESCRT-III mediates the final membrane scission step called abscission, and its dysfunction leads to genome instability.
Abscission is regulated by PLK1 phosphorylation, the ESCRT-III checkpoint, Rab14/MACF2 trafficking, and mechanical tension.
Cytokinesis defects are linked to cancer, genome instability, and potentially developmental disorders.
Live-cell imaging, CRISPR screens, proteomics, and immunofluorescence are commonly used.
Yes, CRISPR knockout of genes like PLK1 and CHMP4C has revealed essential roles in cytokinesis.
The abscission checkpoint delays abscission in response to chromatin bridges or nuclear defects to prevent genome instability.
PLK1 phosphorylates multiple substrates, including ESCRT-III components, to control contractile ring assembly and abscission.
AGO2 localizes to the cytokinetic bridge and may have a non-canonical, RNAi-dependent role in local homeostasis during mitosis.

Conclusion

The mitotic cytokinetic process (GO:1902410) is a fundamental biological process that ensures faithful cell division and genomic stability. Its dysregulation is implicated in cancer and other diseases, making it a critical area of research. Advances in CRISPR technology and imaging have illuminated the molecular players, including PLK1, ESCRT-III, and Rab14. EDITGENE's comprehensive CRISPR services empower researchers to dissect these mechanisms and develop novel therapeutic strategies.

References

  1. 1. Theotoki EI et al.. 2025. Centrosome‑, mitotic spindle‑ and cytokinetic bridge‑specific compartmentalization of AGO2 protein in human liver cells undergoing mitosis: Non‑canonical, RNAi‑dependent, control of local homeostasis.. Mol Med Rep 32(3) PMID: 40641140
  2. 2. Sadler JBA et al.. 2018. A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability.. Proc Natl Acad Sci U S A 115(38):E8900-E8908 PMID: 30181294
  3. 3. Gatta AT et al.. 2019. The ESCRT-machinery: closing holes and expanding roles.. Curr Opin Cell Biol 59:121-132 PMID: 31132588
  4. 4. Fededa JP et al.. 2012. Molecular control of animal cell cytokinesis.. Nat Cell Biol 14(5):440-7 PMID: 22552143
  5. 5. Colicino EG et al.. 2018. Regulating a key mitotic regulator, polo-like kinase 1 (PLK1).. Cytoskeleton (Hoboken) 75(11):481-494 PMID: 30414309
  6. 6. Gibieža P et al.. 2021. Rab14/MACF2 complex regulates endosomal targeting during cytokinesis.. Mol Biol Cell 32(7):554-566 PMID: 33566684
  7. 7. Rani B et al.. 2022. Contribution of integrin adhesion to cytokinetic abscission and genomic integrity.. Front Cell Dev Biol 10:1048717 PMID: 36578785
  8. 8. Gupta DK et al.. 2018. Tension-induced cytokinetic abscission in human fibroblasts.. Oncotarget 9(10):8999-9009 PMID: 29507669
Contact Us
*
*
*
*
How did you hear about us: